|
|||||
|
|
Safety of intramuscular influenza vaccine in patients receiving oral anticoagulation therapy: a single blinded multi-centre randomized controlled clinical trial |
|
| Authors: | Josep Casajuana Bego?a Iglesias Mireia Fàbregas Francesc Fina Joan-Antoni Vallès Rosa Aragonès Mència Benítez and Edurne Zabaleta |
| Institution: | (1) EAP G?tic, Institut Catal? de la Salut, Passatge de la Pau 1, 08001 Barcelona, Spain;(2) SAP Garraf-Alt Pened?s, Institut Catal? de la Salut, C. Manuel Marqu?s, 08800 Vilanova i la Geltr?, Spain;(3) Direcci? Adjunta d'Afers Assistencials, Institut Catal? de la Salut, Av. Gran Via de les Corts Catalanes 587–589, 08007 Barcelona, Spain;(4) SAP Litoral de Barcelona, Institut Catal? de la Salut, C. Lope de Vega 138, 08005 Barcelona, Spain;(5) IDIAP Jordi Gol, Institut Catal? de la Salut, Av. Gran Via de les Corts Catalanes 587–589, 08007 Barcelona, Spain |
| Abstract: | BackgroundInfluenza vaccines are recommended for administration by the intramuscular route. However, many physicians use the subcutaneous route for patients receiving an oral anticoagulant because this route is thought to induce fewer hemorrhagic side effects. Our aim is to assess the safety of intramuscular administration of influenza vaccine in patients on oral anticoagulation therapy. |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |